RxDoctor Payments Data

Christopher Felice, DO

Family Practice · East Setauket, NYNPI 1255911228

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by AstraZeneca at 37.2% of the total. 2025 is the largest year on record at $260, 6.0 times the $44 reported in 2022. Among family practice clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$348in general payments, 2019–2025

Across 16 payments — averaging $21.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$129
  • Pfizer$68
  • Novo Nordisk$44
  • Eisai Inc.$26
  • Acadia Pharmaceuticals Inc$24
  • Amgen$20
  • plus $37 from 2 others

What the payments were for

  • Food & beverage$348100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$348 in reported general payments places this provider in the 95th percentile of 792 family practice providers in New York.

See all family practice providers in New York

Medicare billing

Part B allowed, 2024
$20,301
Medicare patients
122
Services billed
180

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide13$19,277
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$7,136
Albuterol Sulfate HfaAlbuterol Sulfate26$1,433
Atorvastatin Calcium79$1,062
Metformin Hcl33$660
Venlafaxine Hcl ErVenlafaxine Hcl19$644
Omeprazole30$598
Levothyroxine Sodium58$408
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$350
Gabapentin15$293
Lisinopril26$262
Trazodone Hcl22$254
Chlorthalidone12$250
Hydroxyzine Pamoate11$240
Fluticasone Propionate22$134

Paid to pharmacies, not to this prescriber.

Other family practice in East Setauket

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →